Short Interest in icad inc. (NASDAQ:ICAD) Decreases By 25.4%

icad inc. (NASDAQ:ICAD - Get Free Report) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 296,500 shares, a drop of 25.4% from the May 15th total of 397,400 shares. Currently, 1.1% of the company's stock are sold short. Based on an average trading volume of 798,400 shares, the short-interest ratio is presently 0.4 days.

icad Stock Performance

ICAD stock opened at $3.77 on Wednesday. The firm has a fifty day moving average price of $3.46 and a 200 day moving average price of $2.70. icad has a fifty-two week low of $1.18 and a fifty-two week high of $4.02. The firm has a market cap of $103.56 million, a PE ratio of -19.84 and a beta of 1.38.

icad (NASDAQ:ICAD - Get Free Report) last issued its quarterly earnings data on Tuesday, May 13th. The technology company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.04. The business had revenue of $4.87 million for the quarter, compared to the consensus estimate of $4.54 million. icad had a negative return on equity of 15.03% and a negative net margin of 26.63%.

Institutional Trading of icad

A number of institutional investors have recently bought and sold shares of the stock. Thompson Davis & CO. Inc. bought a new position in icad during the fourth quarter valued at $31,000. First Eagle Investment Management LLC boosted its stake in shares of icad by 6.1% during the 4th quarter. First Eagle Investment Management LLC now owns 716,161 shares of the technology company's stock worth $1,311,000 after purchasing an additional 41,000 shares during the period. PKS Advisory Services LLC bought a new position in icad during the 4th quarter valued at about $53,000. Geode Capital Management LLC grew its holdings in icad by 6.6% during the 4th quarter. Geode Capital Management LLC now owns 276,493 shares of the technology company's stock valued at $506,000 after purchasing an additional 17,059 shares during the last quarter. Finally, Perritt Capital Management Inc raised its position in icad by 1.9% in the 4th quarter. Perritt Capital Management Inc now owns 189,100 shares of the technology company's stock worth $346,000 after purchasing an additional 3,600 shares during the period. 24.61% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ICAD. Laidlaw reiterated a "hold" rating on shares of icad in a research report on Thursday, April 17th. Craig Hallum downgraded icad from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 16th. BTIG Research cut shares of icad from a "buy" rating to a "neutral" rating in a research note on Wednesday, April 16th. Finally, Wall Street Zen assumed coverage on shares of icad in a report on Tuesday, May 20th. They issued a "sell" rating on the stock.

About icad

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.